FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034776085> ?p ?o ?g. }

• W2034776085 endingPage "2328" @default.
• W2034776085 startingPage "2319" @default.
• W2034776085 abstract "Introduction: Benign prostatic hyperplasia (BPH) is a very common condition in men over 50 years, often resulting in lower urinary tract symptoms (LUTS). Medical therapy aims at improving quality of life and preventing complications. The range of drugs available to treat LUTS is rapidly expanding.Areas covered: Silodosin is a relatively new α1-adrenoreceptor antagonist that is selective for α1A-adrenergic receptor. While causing smooth muscle relaxation in the lower urinary tract, it minimizes blood pressure-related adverse effects. Tadalafil, a PDEs type 5 inhibitor, is a drug recently approved for the treatment of BPH/LUTS that challenges the standard therapy with α1-blockers, especially in men with concomitant erectile dysfunction (ED). Mirabegron is the first β3-adrenoceptor agonist approved for the treatment of symptoms of overactive bladder. BPH-related detrusor overactivity (DO) may be successfully targeted by mirabegron. Gonadotropin-releasing hormone antagonists, intraprostatic injections with NX-1207 and vitamin D3 receptor analogues exerted beneficial effects on LUTS but need further evaluation in clinical studies.Expert opinion: Choosing the right treatment should be guided by patients’ symptoms, comorbidities and potential side effects of available drugs. Silodosin is a valid option for elderly and for people taking antihypertensive drugs. BPH patients affected by ED can target both conditions with continuous tadalafil therapy. The encouraging data on mirabegron use in BPH-DO have to be further assessed in larger prospective randomized clinical trials." @default.
• W2034776085 created "2016-06-24" @default.
• W2034776085 creator A5013771798 @default.
• W2034776085 creator A5029050000 @default.
• W2034776085 creator A5036655039 @default.
• W2034776085 creator A5039363062 @default.
• W2034776085 creator A5054485016 @default.
• W2034776085 creator A5061623935 @default.
• W2034776085 creator A5072937184 @default.
• W2034776085 creator A5076870899 @default.
• W2034776085 creator A5080243444 @default.
• W2034776085 creator A5091836576 @default.
• W2034776085 date "2014-08-28" @default.
• W2034776085 modified "2023-09-23" @default.
• W2034776085 title "Latest pharmacotherapy options for benign prostatic hyperplasia" @default.
• W2034776085 cites W1496527706 @default.
• W2034776085 cites W1518162929 @default.
• W2034776085 cites W1586377469 @default.
• W2034776085 cites W1590209850 @default.
• W2034776085 cites W1602631556 @default.
• W2034776085 cites W1667697189 @default.
• W2034776085 cites W1880992000 @default.
• W2034776085 cites W1964683861 @default.
• W2034776085 cites W1968860914 @default.
• W2034776085 cites W1969317618 @default.
• W2034776085 cites W1969434853 @default.
• W2034776085 cites W1980086110 @default.
• W2034776085 cites W1982562788 @default.
• W2034776085 cites W1986031402 @default.
• W2034776085 cites W1990732773 @default.
• W2034776085 cites W1994414216 @default.
• W2034776085 cites W1994624472 @default.
• W2034776085 cites W1995256786 @default.
• W2034776085 cites W1999811195 @default.
• W2034776085 cites W2006615433 @default.
• W2034776085 cites W2007681156 @default.
• W2034776085 cites W2009522898 @default.
• W2034776085 cites W2010657543 @default.
• W2034776085 cites W2013459993 @default.
• W2034776085 cites W2018377518 @default.
• W2034776085 cites W2020539470 @default.
• W2034776085 cites W2033685093 @default.
• W2034776085 cites W2033817897 @default.
• W2034776085 cites W2034343992 @default.
• W2034776085 cites W2034512273 @default.
• W2034776085 cites W2035593236 @default.
• W2034776085 cites W2045525995 @default.
• W2034776085 cites W2050093658 @default.
• W2034776085 cites W2057736210 @default.
• W2034776085 cites W2067945145 @default.
• W2034776085 cites W2070979090 @default.
• W2034776085 cites W2072204538 @default.
• W2034776085 cites W2073978463 @default.
• W2034776085 cites W2079619888 @default.
• W2034776085 cites W2082897746 @default.
• W2034776085 cites W2088552272 @default.
• W2034776085 cites W2093633976 @default.
• W2034776085 cites W2093683062 @default.
• W2034776085 cites W2093767304 @default.
• W2034776085 cites W2106355635 @default.
• W2034776085 cites W2106826128 @default.
• W2034776085 cites W2108482421 @default.
• W2034776085 cites W2110991424 @default.
• W2034776085 cites W2120592220 @default.
• W2034776085 cites W2133320940 @default.
• W2034776085 cites W2138057956 @default.
• W2034776085 cites W2138955248 @default.
• W2034776085 cites W2142727765 @default.
• W2034776085 cites W2143023232 @default.
• W2034776085 cites W2157834851 @default.
• W2034776085 cites W2167191243 @default.
• W2034776085 cites W2168839555 @default.
• W2034776085 cites W2199520567 @default.
• W2034776085 cites W2399987985 @default.
• W2034776085 cites W2807400090 @default.
• W2034776085 cites W2949275490 @default.
• W2034776085 cites W4244009026 @default.
• W2034776085 doi "https://doi.org/10.1517/14656566.2014.955470" @default.
• W2034776085 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25164497" @default.
• W2034776085 hasPublicationYear "2014" @default.
• W2034776085 type Work @default.
• W2034776085 sameAs 2034776085 @default.
• W2034776085 citedByCount "17" @default.
• W2034776085 countsByYear W20347760852015 @default.
• W2034776085 countsByYear W20347760852016 @default.
• W2034776085 countsByYear W20347760852017 @default.
• W2034776085 countsByYear W20347760852018 @default.
• W2034776085 countsByYear W20347760852019 @default.
• W2034776085 countsByYear W20347760852020 @default.
• W2034776085 crossrefType "journal-article" @default.
• W2034776085 hasAuthorship W2034776085A5013771798 @default.
• W2034776085 hasAuthorship W2034776085A5029050000 @default.
• W2034776085 hasAuthorship W2034776085A5036655039 @default.
• W2034776085 hasAuthorship W2034776085A5039363062 @default.
• W2034776085 hasAuthorship W2034776085A5054485016 @default.
• W2034776085 hasAuthorship W2034776085A5061623935 @default.
• W2034776085 hasAuthorship W2034776085A5072937184 @default.
• W2034776085 hasAuthorship W2034776085A5076870899 @default.

• next